首页 › 基金 › Kathmere Capital Management, LLC › GMED
Kathmere Capital Management, LLC 对 GMED 的持仓历史
GLOBUS MED INC · 医疗保健
Kathmere Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 GMED(GLOBUS MED INC)255,730 股,市值约 US$19.2M,约占其申报组合的 0.94%,在其申报持仓中市值排名第 23 位。 Kathmere Capital Management, LLC 最近 8 个申报季度中有 8 个季度披露了 GMED 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Kathmere Capital Management, LLC 对 GMED 的持仓演变
Kathmere Capital Management, LLC 于 Q4 2024 首次披露 GMED 持仓:279,176 股(约 US$23.1M)。 该持仓在 Q4 2025 达到峰值 270,888 股,市值约 US$23.7M。 在 8 次申报中,Kathmere Capital Management, LLC 0 次增持、2 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 255,730 股、市值约 US$19.2M,环比减持 -15,767 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 279.18K | $23.09M | 新进 |
| Q1 2025 | 279.18K | $20.44M | 持有 |
| Q2 2025 | 279.18K | $16.48M | 持有 |
| Q3 2025 | 279.33K | $16.00M | 持有 |
| Q4 2025 | 270.89K | $23.65M | 减持 |
| Q1 2026 | 271.13K | $23.36M | 持有 |
| Q2 2026 | 271.50K | $21.45M | 持有 |
| Q3 2026 | 255.73K | $19.15M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GMED 与 13F 数据
GMED(GLOBUS MED INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 GMED,申报仓位最大的包括:KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$123.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GMED 的基金
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.28M 股 · $338.14M · Q2 2026
- Sculptor Capital LP 3.00M 股 · $237.03M · Q2 2026
- Boston Trust Walden Corp 1.64M 股 · $123.07M · Q3 2026
- GW&K Investment Management, LLC 1.47M 股 · $110.29M · Q3 2026
- GENEVA CAPITAL MANAGEMENT LLC 1.25M 股 · $93.58M · Q3 2026
- Madison Avenue Partners, LP 935.22K 股 · $73.89M · Q2 2026
更多关于 Kathmere Capital Management, LLC
常见问题
How long has Kathmere Capital Management, LLC held GMED?
Kathmere Capital Management, LLC has disclosed GMED holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Kathmere Capital Management, LLC's current position in GMED?
As of Q3 2026, Kathmere Capital Management, LLC holds 255.73K shares of GMED (GLOBUS MED INC), valued at $19.15M, representing 0.94% of its reported portfolio and ranking #23.
Has Kathmere Capital Management, LLC been buying or selling GMED?
In the latest 13F filing (Q3 2026), Kathmere Capital Management, LLC reduced its position in GMED. The position peaked in Q4 2025 at 270.89K shares.
Which other funds hold GMED?
Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.